Publications by authors named "Rui-Jie Du"
With the in-depth knowledge of the pathological and physiological characteristics of the intestinal barrier-portal vein/intestinal lymphatic vessels-systemic circulation axis, oral targeted drug delivery is frequently being renewed. With many advantages, such as high safety, convenient administration, and good patient compliance, many researchers have begun to explore targeted drug delivery from intravenous injections to oral administration. Over the past few decades, the fields of materials science and nanomedicine have produced various drug delivery platforms that hold great potential in overcoming the multiple barriers associated with oral drug delivery.
View Article and Find Full Text PDFArticle Synopsis
- The addition of paclitaxel significantly increased the stent's strength, and the drug was effectively released during degradation, promoting fibroblast apoptosis without harming cell viability.
- In animal studies, the new stent maintained esophageal opening and reduced inflammation and scar tissue, indicating its potential as a safe treatment for benign esophageal strictures.
Impact of pandemic on the incidence of venous thromboembolism (VTE) in non-COVID-19 patients is undetermined. Thus, a nationwide multicenter retrospective survey was conducted to evaluate the disease burden in non-COVID-19 population. This multi-center survey involved 94 hospitals from 24 provinces in the mainland of China, and collected data on non-COVID-19 patients admitted to the radiology departments due to VTE between January 24 and April 16, 2020.
View Article and Find Full Text PDF